Overview

Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
To investigate the effectiveness of BI 1026706 powder for reconstitution of an oral solution compared to placebo and the relative effectiveness compared to Celecoxib.
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Celecoxib
Pharmaceutical Solutions